We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.88B 24.97%
3,600,000
-650,000
-15% -$324M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$1.85B 24.54%
8,800,000
+1,500,000
+21% +$299M
PTCT icon
3
PTC Therapeutics
PTCT
$6.37B
$197M 2.61%
6,764,000
-100,000
-1% -$2.8M
NBIX icon
4
Neurocrine Biosciences
NBIX
$17.7B
$141M 1.87%
1,023,739
-24,261
-2% -$3.31M
INCY icon
5
Incyte
INCY
$23.5B
$125M 1.65%
2,187,181
+1,951,181
+827% +$117M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.68B
$122M 1.62%
3,572,000
-1,078,000
-23% -$32.1M
CYTK icon
7
Cytokinetics
CYTK
$11B
$107M 1.42%
+1,525,688
New +$118M
ARGX icon
8
argenx
ARGX
$57.4B
$104M 1.38%
264,000
-54,000
-17% -$20.9M
DCPH
9
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$92.8M 1.23%
5,900,000
+700,000
+13% +$10.8M
AGIO icon
10
Agios Pharmaceuticals
AGIO
$2.16B
$86.7M 1.15%
2,964,000
-560,000
-16% -$15M
IMVT icon
11
Immunovant
IMVT
$8.09B
$69.9M 0.93%
2,164,000
+728,000
+51% +$26.6M
SNY icon
12
Sanofi
SNY
$104B
$63.1M 0.84%
1,298,000
+262,000
+25% +$12.8M
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.97B
$61.4M 0.81%
12,260,000
+2,724,000
+29% +$18.5M
XRAY icon
14
Dentsply Sirona
XRAY
$2.59B
$58M 0.77%
1,747,055
-148,945
-8% -$5.09M
TVTX icon
15
Travere Therapeutics
TVTX
$5.33B
$57.8M 0.77%
7,500,000
+116,000
+2% +$979K
MDT icon
16
Medtronic
MDT
$107B
$55.1M 0.73%
632,359
+24,359
+4% +$2.08M
OFIX icon
17
Orthofix Medical
OFIX
$455M
$53.7M 0.71%
3,700,000
+100,000
+3% +$1.38M
NVRO
18
DELISTED
NEVRO CORP.
NVRO
$52.3M 0.69%
3,624,000
+448,000
+14% +$7.41M
NVO
19
Novo Nordisk
NVO
$216B
$51.4M 0.68%
400,000
+4,000
+1% +$476K
EXAS
20
DELISTED
Exact Sciences
EXAS
$50.5M 0.67%
730,648
-41,173
-5% -$2.6M
CYTK icon
21
CALL
Cytokinetics
CYTK
$11B
$49.1M 0.65%
+700,000
New +$54.1M
DOCU
22
DocuSign
DOCU
$9.63B
$47.9M 0.63%
803,675
+235,675
+41% +$13.3M
IRWD icon
23
Ironwood Pharmaceuticals
IRWD
$611M
$47M 0.62%
5,400,000
-300,000
-5% -$3.64M
KO icon
24
Coca-Cola
KO
$354B
$46M 0.61%
+752,662
New +$45.2M
MDGL icon
25
Madrigal Pharmaceuticals
MDGL
$12.6B
$44.9M 0.6%
168,000
+118,000
+236% +$27.8M
1
2 3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.